Membership Directory - Corporate

ReactomeAI

About

ReactomeAI is the commercial spin-off of the open-access Reactome Project. Reactome.org would continue to provide freely available pathway data, while ReactomeAI offers bespoke curation of drug and target pathways, available exclusively to paying clients. Building on the Reactome knowledge base, ReactomeAI deploys advanced AI tools to identify novel drug candidates, map related research, and uncover new therapeutic target pathways. This hybrid model ensures the sustainability of the open resource while enabling industry partners to access enhanced, proprietary insights for drug discovery.

Savings Partners